AI summary by TwinMind

How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks | Huberman Lab Podcast

Andrew Huberman

2h 9m 1s

Introduction and Overview

  • Andrew Huberman, professor of neurobiology/ophthalmology at Stanford
  • Focus: psilocybin specifically (not other psychedelics)
  • Psilocybin = psychedelic that modifies psyche, changes consciousness
  • Can fundamentally change perception, memories, thoughts, feelings during and long after use
  • Growing excitement for treating depression, alcohol abuse, addictions, OCD, eating disorders

Chemical Structure and Mechanism

  • Psilocybin is a tryptamine (T-R-Y-P, not "trip")
  • Very similar chemical structure to serotonin
  • Main effect: mimics serotonin by binding strongly to serotonin 2A receptors
  • Psilocybin → converted to psilocin in gut → psilocin crosses blood-brain barrier
  • Selectivity for serotonin 2A receptor explains specific effects vs general serotonin activity

Serotonin 2A Receptor Distribution and Effects

  • High expression in neocortex (prefrontal cortex, visual cortex)
  • Prefrontal cortex: context understanding, behavioral switching
  • Visual cortex: explains visual hallucinations (even with eyes closed)
  • Located on apical dendrites of pyramidal neurons
  • Activation increases lateral communication across brain areas
  • Reduces modularity, increases integration between normally separate brain regions

Dosage and Conversion

  • 1000 milligrams = 1 gram
  • Magic mushrooms contain ~1% psilocybin
  • 1 gram mushrooms ≈ 10 milligrams psilocybin
  • Clinical study dosages:
    • Microdosing: 1-3 milligrams daily
    • Low dose: 10 milligrams
    • Therapeutic dose: 25-30 milligrams
    • "Heroic dose": ~50 milligrams (5 grams mushrooms)
  • Mushroom psilocybin concentration varies 0.5-2% between strains/batches

Set and Setting for Therapeutic Sessions

  • Set: mindset of person taking psilocybin
  • Setting: physical/social environment
  • Safety requirements:
    • No windows to jump from, no traffic access
    • 1-2 sober guides present at all times
    • Safe, controlled indoor environment
  • Eye mask/eyes closed for majority of session
    • Allows internal focus vs external visual hallucinations
    • Critical for therapeutic benefit
  • Music component:
    • 4-6 hour journey duration
    • Early: soft, minimal vocals
    • Peak (2-3 hours): intense percussion, drums
    • Later: softer, melodic, female voices
    • End: nature sounds

Subjective Experience and Journey Structure

  • Duration: 4-6 hours total
  • Onset: 30-45 minutes after ingestion
  • Peak: maximum emotional intensity + anxiety (ego dissolution phase)
  • Gradual taper: hours 3-6 ("parachuting back in")
  • Perceptual blending (synesthesia):
    • Breathing linked to music/visuals
    • Touch sensations affecting perceived sounds
    • Visual hallucinations merged with audio
  • Empty stomach recommended (no food 4+ hours prior)

Brain Network Changes During Journey

  • Expanded functional connectivity across brain regions
  • Reduced hierarchical organization (bottom-up processing)
  • Broadened thalamic gating (more sensory information flows through)
  • Less modular, more integrated brain activity
  • Four main theoretical models (all likely true):
    • Default mode network changes
    • Enhanced between-network connectivity
    • Reduced hierarchical processing
    • Increased lateral communication

Therapeutic Outcomes and Subjective Predictors

  • Key positive predictors:
    • Oceanic boundlessness experience
    • Mystical/spiritual feelings
    • Experience of unity/connectedness
    • Blissful states
    • Insightfulness
  • Less important for outcomes:
    • Complex visual imagery/hallucinations
    • Synesthesia intensity
  • Anxiety levels: moderate anxiety/ego dissolution helpful, but extreme anxiety negatively correlated with benefits
  • Physiological sigh breathing technique being incorporated to manage excessive anxiety during sessions

Safety and Contraindications

  • Absolute contraindications:
    • Pregnant/breastfeeding women
    • Personal/family history of psychosis, bipolar disorder, schizophrenia
    • People under 25 years old (brain still developing)
    • Current SSRI/antidepressant use
  • Legal status: Schedule I drug (illegal in US except Oregon decriminalization, some clinical trials)
  • Requires medical supervision and proper therapeutic setting

Neuroplasticity Mechanisms

  • Not primarily neurogenesis (new neuron creation)
  • Primary mechanism: growth of dendritic spines and dendrites
    • New "mushroom-shaped" protrusions on pyramidal neurons
    • Increased connections between neurons
    • Structural changes persist after drug effects wear off
  • Depression associated with reduced dendritic spines in frontal cortex
  • Psilocybin may restore/increase spine density
  • Animal studies use ~double human therapeutic doses

Music and Emotional Processing Changes

  • Post-psilocybin: enhanced positive emotional response to liked music
  • Reduced negative emotional impact of sad music
  • Changes persist long after session ends
  • Brain imaging shows altered reward circuitry activation
  • Ventral tegmental area and mesolimbic pathway involvement

Clinical Trial Results for Depression

  • Strong evidence for:
    • Cancer-related depression/anxiety
    • Treatment-resistant depression
  • Moderate evidence for:
    • Alcohol use disorder
    • Tobacco addiction
  • Limited evidence for:
    • OCD, cluster headaches, AIDS-related demoralization

Major Depression Clinical Outcomes

  • Single 25mg dose study (New England Journal of Medicine 2021):
    • 25mg significantly better than 1mg control
    • 10mg showed no significant difference vs control
    • Benefits sustained at 12 weeks post-treatment
    • Higher doses = greater benefits but more adverse events
  • Two-session protocols (25mg each, ~1 week apart):
    • 60-75% of patients show substantial improvement
    • Effects 2.5x greater than psychotherapy alone
    • 4x greater than standard antidepressant medications
    • Combined with ~11 hours supportive psychotherapy

Adverse Events

  • Higher doses = more adverse events
  • Range from mild (headaches) to severe (suicidal ideation)
  • Most adverse events transient
  • Proper set/setting and guide training crucial for minimizing risks
  • Real-time anxiety management techniques being incorporated

Future Research Directions

  • More studies on creativity enhancement
  • Neuroplasticity mechanism clarification
  • Optimal dosing protocols
  • Integration with various therapy modalities
  • Long-term follow-up studies
  • Expansion to other psychiatric conditions

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome